Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilaris

— Health news and commentary from around the Web gathered by the staff

MedicalToday

Note that some links may require subscriptions.

An obituary captured what often goes overlooked in the opioid epidemic -- the . (ABC News)

Did Leonardo da Vinci have a that helped make him a painting genius? (CNN)

The FDA turned down a bid by Novartis to for the inflammatory-disease drug canakinumab (Ilaris) to include secondary cardiovascular prevention. (Reuters)

On the heels of an announcement that the CDC will begin weekly reporting of acute flaccid myelitis, more confirmed and suspected cases popped up across the Midwest, including , and . (Associated Press, Channel3000)

New documents released from a Senate investigation into the opioid epidemic suggested that drug maker Insys drove by "owning" physicians and firing sales people who failed to recruit enough doctors to talk about the drug. (FiercePharma)

Are conspiracy theories driving cities' decisions to from public water supplies? (NBC News)

As a growing number of consumers shun "dieting" in favor of "wellness," (CNBC)

Patients with no other options for are overwhelming emergency departments. (STAT)

Merck announced that patients with advanced/metastatic kidney cancer if they initially received pembrolizumab (Keytruda) and axitinib (Inlyta) instead of the current standard sunitinib (Sutent).

The USDA suspended , pending an investigation into the Polish government's response to an outbreak of African swine fever. (Feedstuffs)

A study based on a Gallup survey suggested that , the less likely they are to want the same things in life. (Los Angeles Times, Science)

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com